Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction Summary Researchers developed a novel immunotherapeutic strategy that reprograms the IL-18 pathway to combat refractory malignancies in mice. By engineering a “decoy” Read More
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study Summary A multicenter study investigated the impact of extranodal (EN) Read More
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial Summary In a phase 1 trial, researchers explored the safety and efficacy of allogeneic natural killer (NK) cells Read More
1 Million+ Views and Counting..!
Now, it has been 6 years since it was launched in late July 2018 and is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
